Mapping metals in Parkinson's and normal brain using rapid-scanning x-ray fluorescence

Rapid-scanning x-ray fluorescence (RS-XRF) is a synchrotron technology that maps multiple metals in tissues by employing unique hardware and software to increase scanning speed. RS-XRF was validated by mapping and quantifying iron, zinc and copper in brain slices from Parkinson's disease (PD) and unaffected subjects. Regions and structures in the brain were readily identified by their metal complement and each metal had a unique distribution. Many zinc-rich brain regions were low in iron and vice versa. The location and amount of iron in brain regions known to be affected in PD agreed with analyses using other methods. Sample preparation is simple and standard formalin-fixed autopsy slices are suitable. RS-XRF can simultaneously and non-destructively map and quantify multiple metals and holds great promise to reveal metal pathologies associated with PD and other neurodegenerative diseases as well as diseases of metal metabolism.

[1]  Alberto Bravin,et al.  Memory and survival after microbeam radiation therapy. , 2008, European journal of radiology.

[2]  Richard Buist,et al.  A comparison of rapid-scanning X-ray fluorescence mapping and magnetic resonance imaging to localize brain iron distribution. , 2008, European journal of radiology.

[3]  Antonio Lanzirotti,et al.  Evidence That the ZNT3 Protein Controls the Total Amount of Elemental Zinc in Synaptic Vesicles , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[4]  Tore Syversen,et al.  Leaching of Trace Elements from Biological Tissue by Formalin Fixation , 2008, Biological Trace Element Research.

[5]  Uwe Bergmann,et al.  Archimedes Brought to Light , 2007 .

[6]  J. Gitlin,et al.  Copper and iron disorders of the brain. , 2007, Annual review of neuroscience.

[7]  Reiko Meguro,et al.  Nonheme-iron histochemistry for light and electron microscopy: a historical, theoretical and technical review. , 2007, Archives of histology and cytology.

[8]  Jim Mintz,et al.  Brain ferritin iron may influence age- and gender-related risks of neurodegeneration , 2007, Neurobiology of Aging.

[9]  N. Scott,et al.  Environmental risk factors for Parkinson’s disease and parkinsonism: the Geoparkinson study , 2007, Occupational and Environmental Medicine.

[10]  P. Francis,et al.  Metals ions and neurodegeneration , 2007, BioMetals.

[11]  R. Service,et al.  Brilliant X-rays Reveal Fruits of a Brilliant Mind , 2006, Science.

[12]  Antonio Lanzirotti,et al.  Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. , 2006, Journal of structural biology.

[13]  J. Dobson,et al.  Mapping and characterization of iron compounds in Alzheimer's tissue. , 2006, Journal of Alzheimer's disease : JAD.

[14]  C. Datz,et al.  Diagnostic value of quantitative hepatic copper determination in patients with Wilson's Disease. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[15]  N. Palomero-Gallagher,et al.  Imaging of copper, zinc, and other elements in thin section of human brain samples (hippocampus) by laser ablation inductively coupled plasma mass spectrometry. , 2005, Analytical chemistry.

[16]  St. Zaleski Das Eisen der Organe bei Morbus maculosus Werlhofii , 1887, Archiv für experimentelle Pathologie und Pharmakologie.

[17]  Dr. M. Perls Nachweis von Eisenoxyd in gewissen Pigmenten , 1867, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.

[18]  石原 良子 Investigation of cellular metallic elements in single neurons of human brain tissues , 2005 .

[19]  C. Frederickson,et al.  Is zinc the link between compromises of brain perfusion (excitotoxicity) and Alzheimer's disease? , 2005, Journal of Alzheimer's disease : JAD.

[20]  E. Haacke,et al.  Imaging iron stores in the brain using magnetic resonance imaging. , 2005, Magnetic resonance imaging.

[21]  J. Connor,et al.  Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.

[22]  Joseph Jankovic,et al.  Neurodegenerative disease and iron storage in the brain , 2004, Current opinion in neurology.

[23]  Alberto Gatti,et al.  The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Danscher,et al.  The dithizone, Timm's sulphide silver and the selenium methods demonstrate a chelatable pool of zinc in CNS , 1985, Histochemistry.

[25]  A. Henwood Current applications of orcein in histochemistry. A brief review with some new observations concerning influence of dye batch variation and aging of dye solutions on staining , 2003, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[26]  Shigeyoshi Fujisawa,et al.  Investigation of cellular metallic elements in single neurons of human brain tissues , 2002, Neuroreport.

[27]  P. Hof,et al.  Cytoarchitecture of the human cerebral cortex: MR microscopy of excised specimens at 9.4 Tesla. , 2002, AJNR. American journal of neuroradiology.

[28]  J. Nacher,et al.  Cytochemical techniques for zinc and heavy metals localization in nerve cells , 2002, Microscopy research and technique.

[29]  D. Allsop,et al.  alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro. , 2001, Free radical biology & medicine.

[30]  R. Brookmeyer,et al.  Aging and the public health effects of dementia. , 2001, The New England journal of medicine.

[31]  Shigeyoshi Fujisawa,et al.  XAFS spectroscopy of a single neuron from a patient with Parkinson's disease , 2001 .

[32]  Shigeyoshi Fujisawa,et al.  XANES spectroscopy of a single neuron from a patient with Parkinson's disease. , 2001, Journal of synchrotron radiation.

[33]  I. Orion,et al.  Response of avian embryonic brain to spatially segmented x-ray microbeams. , 2001, Cellular and molecular biology.

[34]  John Hardy,et al.  The A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity , 2000, The Journal of Neuroscience.

[35]  E. Masliah,et al.  α-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress , 2000 .

[36]  Josemir W Sander,et al.  The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. , 2000, Brain : a journal of neurology.

[37]  E. Masliah,et al.  alpha-synuclein promotes mitochondrial deficit and oxidative stress. , 2000, The American journal of pathology.

[38]  P. van Eyken,et al.  Value of histochemical stains for copper in the diagnosis of Wilson's disease , 1998, Histopathology.

[39]  T. S. St. Pierre,et al.  The effect of histological processing on the form of iron in iron-loaded human tissues. , 1997, Biochimica et biophysica acta.

[40]  K. Batts,et al.  Essential and toxic element concentrations in fresh and formalin-fixed human autopsy tissues. , 1995, Clinical chemistry.

[41]  C. Morris,et al.  Iron histochemistry of the substantia nigra in Parkinson's disease. , 1994, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[42]  C. Marsden,et al.  Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia. , 1993, Advances in neurology.

[43]  C. Morris,et al.  Brain iron homeostasis. , 1992, Journal of inorganic biochemistry.

[44]  C. Morris,et al.  Histochemical distribution of non-haem iron in the human brain. , 1992, Acta anatomica.

[45]  C. Marsden,et al.  Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia , 1992 .

[46]  C D Marsden,et al.  Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. , 1991, Brain : a journal of neurology.

[47]  P Riederer,et al.  Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains , 1991, Journal of neurochemistry.

[48]  R Henderson,et al.  The structure of bacteriorhodopsin and its relevance to the visual opsins and other seven-helix G-protein coupled receptors. , 1990, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[49]  K. Jellinger,et al.  Brain iron and ferritin in Parkinson's and Alzheimer's diseases , 1990, Journal of neural transmission. Parkinson's disease and dementia section.

[50]  C. Marsden,et al.  Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease , 1989, Journal of neurochemistry.

[51]  Y Agid,et al.  Biochemistry of Parkinson's disease 28 years later: A critical review , 1989, Movement disorders : official journal of the Movement Disorder Society.

[52]  B. Drayer,et al.  Imaging of the aging brain. Part I. Normal findings. , 1988, Radiology.

[53]  C. Marsden,et al.  INCREASED NIGRAL IRON CONTENT IN POSTMORTEM PARKINSONIAN BRAIN , 1987, The Lancet.

[54]  P. Gaspar,et al.  Biochemical neuropathology of Parkinson's disease. , 1984, Advances in neurology.

[55]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.

[56]  G Gōmōri,et al.  Microtechnical Demonstration of Iron: A Criticism of its Methods. , 1936, The American journal of pathology.